MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
AZN — AstraZeneca PLC
NYSEAstraZeneca PLC
$156.90
-0.80(-0.51%)
- O
- 158.46
- H
- 158.80
- L
- 156.41
- V
- 2.64M
⏱️ End-of-day dataAs of Oct 2, 2026
AstraZeneca PLC Statistics
Total Valuation
| Market Cap | $258.35B |
| Enterprise Value | $260.19B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | 2026-08-07 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | 1.55B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | 79.64 |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 51.27 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 1,418.72 |
| P/OCF Ratio | 648.79 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 844.49 |
| EV / Sales | n/a |
| EV / EBITDA | 458.64 |
| EV / EBIT | 604.11 |
| EV / FCF | 1,428.82 |
Financial Position
| Current Ratio | 0.91 |
| Quick Ratio | n/a |
| Debt / Equity | 0.55 |
| Debt / EBITDA | 4.58 |
| Debt / FCF | 14.26 |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | 6.50% |
| Return on Assets (ROA) | 2.70% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $3,206 |
| Employee Count | 96,100 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | $83.30M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | -6.22% |
| 50-Day Moving Average | $163.34 |
| 200-Day Moving Average | $182.11 |
| Relative Strength Index (RSI) | 37.04 |
| Average Volume (20 Days) | 3,010,378 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | $1.26B |
| Operating Income | $424.60M |
| Pretax Income | $391.40M |
| Net Income | $308.10M |
| EBITDA | $567.30M |
| EBIT | $430.70M |
| Earnings Per Share | $1.97 |
Balance Sheet
| Cash & Cash Equivalents | $756.00M |
| Total Debt | $2.60B |
| Net Cash | -$1.84B |
| Net Cash Per Share | $-1.19 |
| Equity (Book Value) | $4.74B |
| Book Value Per Share | $3.06 |
| Working Capital | -$295.70M |
Cash Flow
| Operating Cash Flow | $398.20M |
| Capital Expenditures | -$53.90M |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | $182.10M |
| FCF Per Share | $0.12 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
| Dividend Per Share | $1.59 |
| Dividend Yield | 1.01% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 1.26% |
| FCF Yield | 0.07% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
| Lynch Fair Value | $29.55 |
| Lynch Upside | -81.17% |
| Graham Number | $11.65 |
| Graham Upside | -92.57% |
Stock Splits
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |